Gene clues in Egg-Support cells may predict embryo success
NCT ID NCT07197255
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study looks at gene activity in cumulus cells (cells that surround eggs) from 10 women with PCOS undergoing a special lab-based egg maturation technique called CAPA-IVM. Researchers want to see if these gene patterns can predict which eggs will develop into healthy embryos. The goal is to find a non-invasive way to select the best embryos without harming the eggs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 10 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Women with PCOS diagnosed according to the Rotterdam 2003 criteria who are indicated for CAPA-IVM treatment at IVFMD, My Duc Hospital, Ho Chi Minh City, Vietnam.
- Ages
-
18 to 38 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women 18-38 years * BMI =\< 32kg/m2 * Diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam 2003 criteria, meet at least 2 of the following 3 features: (1) Oligo-ovulation or anovulation. (2) Clinical and/or biochemical signs of hyperandrogenism (3) Polycystic ovarian morphology on ultrasound. * Indicated for CAPA-IVM treatment. * Serum AMH ≥ 4 ng/mL (28.57 pmol/L). * Antral follicle count (AFC) ≥ 24 follicles in both ovaries at the time of CAPA-IVM indication. * Signed informed consent to participate in the study. Exclusion Criteria: * Retrieved sperm from surgical procedures * Previous IVF cycle with total immature oocytes
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Capacitation ivm are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
My Duc Hospital
RECRUITINGHo Chi Minh City, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Steak solution? lean beef may tame blood sugar in teens with PCOS
- Can diet plus inositol or metformin tame insulin resistance in PCOS?
- Can a gut microbiome transplant boost fertility in PCOS?
- A simple blood test may flag hidden insulin problems in PCOS
- Can tracking PCOS over time unlock better care?
- Could two common supplements tame PCOS hormone chaos?